
Madrigal Pharmaceuticals, Inc.
USD546.79
+11.10 (+2.07%)
CEO
William J. Sibold
IPO Date
2007-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$537.61
Prev. Close
$535.69
Day Low
$534.50
Day High
$547.64
52W Low
$286.44
52W High
$615.00
Market Cap
$12.61B
Volume
0.19M
Madrigal Pharmaceuticals Completes Enrollment of the 52 Week Liver Biopsy Patient Population in the Phase 3 MAESTRO-NASH Study of Resmetirom